Abstracts

Search by keyword or author name.

Showing 737 abstracts.

Long-Term (72 Weeks) Immunogenicity and Increased Response Rates After a Second Dose of Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Children and Youth

Conference

18th Conference on Retroviruses & Opportunistic Infections

Study

P1065

The HIV prevalence of women entering labour with unknown HIV status who accepted or declined VCT

Conference

South African Society of Obstetricians & Gynaecologists

Study

P1031A

Safety and Immunogenicity of HIN1 Influenza Immunization in HIV-1 Perinatally Infected Children and Youth

Conference

48th Annual Meeting of Infectious Diseases Society of Amercia

Study

P1088, P1089

Safety and Immunogenicity of Two Doses of Monovalent Pandemic H1N1 (pH1N1) Influenza Vaccine in HIV-Infected Pregnant Women

Conference

48th Annual Meeting of Infectious Diseases Society of Amercia

Study

P1086

Raltegravir Pharmacokinetics during Pregnancy

Conference

50th Interscience Conference on Antimicrobial Agents and Chemotherapy

Study

P1026S

Pediatric Population Pharmacokinetics of Efavirenz (EFV) – High Dose Requirements in Infants Likely Due to Reduced Absorption

Conference

50th Interscience Conference on Antimicrobial Agents and Chemotherapy

Study

P1021

Predictors of Cardiac Dysfunction among Children and Adolescents Perinatally-Infected with HIV-1

Conference

XVIII International AIDS Conference

A Randomised Trial of Protease Inhibitor vs Non-Nucleoside Reverse Transcriptase Inhibitor Combination Antiretroviral Regimens and Viral Load Treatment Switching Strategies in HIV-1-Infected Antiretroviral-Naive Children Age 30 Days and

Conference

2nd International Workshop on HIV Pediatrics

Pharmacokinetics and Safety of A Novel Chewable Pediatric Fixed-Dose Combination (FDC) of Zidovudine (ZDV), Lamivudine (3TC), Nevirapine (NVP): in HIV-Infected Thai Children

Conference

2nd International Workshop on HIV Pediatrics

Study

P1069

Neutropenia, anemia and skin-rash among HIV exposed infants receiving nevirapine and cotrimoxazole compared to cotrimoxazole prophylaxis alone

Conference

2nd International Workshop on HIV Pediatrics